DOI QR코드

DOI QR Code

Effects of mTORC1 inhibition on proteasome activity and levels

  • Park, Seo Hyeong (Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine) ;
  • Choi, Won Hoon (BK21 FOUR Biomedical Science Program, Seoul National University College of Medicine) ;
  • Lee, Min Jae (Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine)
  • Received : 2022.02.03
  • Accepted : 2022.03.08
  • Published : 2022.04.30

Abstract

The mechanistic target of rapamycin (mTOR) regulates numerous extracellular and intracellular signals involved in the maintenance of cellular homeostasis and cell growth. mTOR also functions as an endogenous inhibitor of autophagy. Under nutrient-rich conditions, mTOR complex 1 (mTORC1) phosphorylates the ULK1 complex, preventing its activation and subsequent autophagosome formation, while inhibition of mTORC1 using either rapamycin or nutrient deprivation induces autophagy. Autophagy and proteasomal proteolysis provide amino acids necessary for protein translation. Although the connection between mTORC1 and autophagy is well characterized, the association of mTORC1 inhibition with proteasome biogenesis and activity has not been fully elucidated yet. Proteasomes are long-lived cellular organelles. Their spatiotemporal rather than homeostatic regulation could be another adaptive cellular mechanism to respond to starvation. Here, we reviewed several published reports and the latest research from our group to examine the connection between mTORC1 and proteasome. We have also investigated and described the effect of mTORC1 inhibition on proteasome activity using purified proteasomes. Since mTORC1 inhibitors are currently evaluated as treatments for several human diseases, a better understanding of the link between mTORC1 activity and proteasome function is of utmost importance.

Keywords

Acknowledgement

This work was supported by grants from the NRF (2020R1A5A1019023 and 2021R1A2C2008023 to M.J.L.), the Korea Health Industry Development Institute and Korea Dementia Research Center (HU21C0071 to M.J.L.), and the Creative-Pioneering Researchers Program through Seoul National University, and the BK21 FOUR programs (W.H.C. and S.H.P.).

References

  1. Saxton RA and Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168, 960-976 https://doi.org/10.1016/j.cell.2017.02.004
  2. Kim J and Guan KL (2019) mTOR as a central hub of nutrient signalling and cell growth. Nat Cell Biol 21, 63-71 https://doi.org/10.1038/s41556-018-0205-1
  3. Laplante M and Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149, 274-293 https://doi.org/10.1016/j.cell.2012.03.017
  4. Inoki K, Corradetti MN and Guan KL (2005) Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 37, 19-24 https://doi.org/10.1038/ng1494
  5. Liu GY and Sabatini DM (2020) mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21, 183-203 https://doi.org/10.1038/s41580-019-0199-y
  6. Jung CH, Ro SH, Cao J, Otto NM and Kim DH (2010) mTOR regulation of autophagy. FEBS Lett 584, 1287-1295 https://doi.org/10.1016/j.febslet.2010.01.017
  7. Chantranupong L, Wolfson RL and Sabatini DM (2015) Nutrient-sensing mechanisms across evolution. Cell 161, 67-83 https://doi.org/10.1016/j.cell.2015.02.041
  8. Vabulas RM and Hartl FU (2005) Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310, 1960-1963 https://doi.org/10.1126/science.1121925
  9. Takeshige K, Baba M, Tsuboi S, Noda T and Ohsumi Y (1992) Autophagy in yeast demonstrated with proteinasdeficient mutants and conditions for its induction. J Cell Biol 119, 301-311 https://doi.org/10.1083/jcb.119.2.301
  10. Milani M, Rzymski T, Mellor HR et al (2009) The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 69, 4415-4423 https://doi.org/10.1158/0008-5472.CAN-08-2839
  11. Ding WX, Ni HM, Gao W et al (2007) Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 171, 513-524 https://doi.org/10.2353/ajpath.2007.070188
  12. Zhu K, Dunner K Jr and McConkey DJ (2010) Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 29, 451-462 https://doi.org/10.1038/onc.2009.343
  13. Kim E, Park S, Lee JH et al (2018) Dual function of USP14 deubiquitinase in cellular proteasomal activity and autophagic flux. Cell Rep 24, 732-743 https://doi.org/10.1016/j.celrep.2018.06.058
  14. Lee JH, Park S, Kim E and Lee MJ (2019) Negative-feedback coordination between proteasomal activity and autophagic flux. Autophagy 15, 726-728 https://doi.org/10.1080/15548627.2019.1569917
  15. Kim J, Kundu M, Viollet B and Guan KL (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13, 132-141 https://doi.org/10.1038/ncb2152
  16. Egan DF, Shackelford DB, Mihaylova MM et al (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456-461 https://doi.org/10.1126/science.1196371
  17. Klionsky DJ, Abdel-Aziz AK, Abdelfatah S et al (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). Autophagy 17, 1-382 https://doi.org/10.1080/15548627.2020.1797280
  18. Codogno P and Meijer AJ (2005) Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ 12 Suppl 2, 1509-1518 https://doi.org/10.1038/sj.cdd.4401751
  19. Abraham RT and Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14, 483-510 https://doi.org/10.1146/annurev.immunol.14.1.483
  20. Thoreen CC, Kang SA, Chang JW et al (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284, 8023-8032 https://doi.org/10.1074/jbc.M900301200
  21. Zhang Y, Nicholatos J, Dreier JR et al (2014) Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 513, 440-443 https://doi.org/10.1038/nature13492
  22. Zhao J, Zhai B, Gygi SP and Goldberg AL (2015) mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy. Proc Natl Acad Sci U S A 112, 15790-15797 https://doi.org/10.1073/pnas.1521919112
  23. Appenzeller-Herzog C and Hall MN (2012) Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol 22, 274-282 https://doi.org/10.1016/j.tcb.2012.02.006
  24. Hamazaki J and Murata S (2020) ER-resident transcription factor nrf1 regulates proteasome expression and beyond. Int J Mol Sci 21, 3683 https://doi.org/10.3390/ijms21103683
  25. Sha Z and Goldberg AL (2014) Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97. Curr Biol 24, 1573-1583 https://doi.org/10.1016/j.cub.2014.06.004
  26. Zhang Y and Manning BD (2016) Zhang & Manning reply. Nature 529, 2-3
  27. Zhao J, Garcia GA and Goldberg AL (2016) Control of proteasomal proteolysis by mTOR. Nature 529, E1-E2 https://doi.org/10.1038/nature16472
  28. Lokireddy S, Kukushkin NV and Goldberg AL (2015) cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc Natl Acad Sci U S A 112, 7176-7185
  29. VerPlank JJS, Lokireddy S, Zhao J and Goldberg AL (2019) 26S proteasomes are rapidly activated by diverse hormones and physiological states that raise cAMP and cause Rpn6 phosphorylation. Proc Natl Acad Sci U S A 116, 4228-4237 https://doi.org/10.1073/pnas.1809254116
  30. Rousseau A and Bertolotti A (2016) An evolutionarily conserved pathway controls proteasome homeostasis. Nature 536, 184-189 https://doi.org/10.1038/nature18943
  31. Hanssum A, Zhong Z, Rousseau A, Krzyzosiak A, Sigurdardottir A and Bertolotti A (2014) An inducible chaperone adapts proteasome assembly to stress. Mol Cell 55, 566-577 https://doi.org/10.1016/j.molcel.2014.06.017
  32. Han DH, Na HK, Choi WH et al (2014) Direct cellular delivery of human proteasomes to delay tau aggregation. Nat Commun 5, 5633 https://doi.org/10.1038/ncomms6633
  33. Choi WH, de Poot SA, Lee JH et al (2016) Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun 7, 10963 https://doi.org/10.1038/ncomms10963
  34. Shin SK, Kim JH, Lee JH et al (2017) Docosahexaenoic acid-mediated protein aggregates may reduce proteasome activity and delay myotube degradation during muscle atrophy in vitro. Exp Mol Med 49, e287 https://doi.org/10.1038/emm.2016.133
  35. Asano S, Fukuda Y, Beck F et al (2015) Proteasomes. A molecular census of 26S proteasomes in intact neurons. Science 347, 439-442 https://doi.org/10.1126/science.1261197
  36. Pack CG, Yukii H, Toh-e A et al (2014) Quantitative live-cell imaging reveals spatio-temporal dynamics and cytoplasmic assembly of the 26S proteasome. Nat Commun 5, 3396 https://doi.org/10.1038/ncomms4396
  37. Tanaka K and Ichihara A (1989) Half-life of proteasomes (multiprotease complexes) in rat liver. Biochem Biophys Res Commun 159, 1309-1315 https://doi.org/10.1016/0006-291X(89)92253-5
  38. Russell SJ, Steger KA and Johnston SA (1999) Subcellular localization, stoichiometry, and protein levels of 26 S proteasome subunits in yeast. J Biol Chem 274, 21943-21952 https://doi.org/10.1074/jbc.274.31.21943
  39. Peters LZ, Hazan R, Breker M, Schuldiner M and Ben-Aroya S (2013) Formation and dissociation of proteasome storage granules are regulated by cytosolic pH. J Cell Biol 201, 663-671 https://doi.org/10.1083/jcb.201211146
  40. Yasuda S, Tsuchiya H, Kaiho A et al (2020) Stress- and ubiquitylation-dependent phase separation of the proteasome. Nature 578, 296-300 https://doi.org/10.1038/s41586-020-1982-9
  41. Choi WH, Yun Y, Park S et al (2020) Aggresomal sequestration and STUB1-mediated ubiquitylation during mammalian proteaphagy of inhibited proteasomes. Proc Natl Acad Sci U S A 117, 19190-19200 https://doi.org/10.1073/pnas.1920327117